Model systems for platelet receptor shedding

References

• Nieswandt B, Pleines I, Bender M. Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J Thromb Haemost 2011;9(Suppl 1):92–104.
   PubMed Web of Science ®Google Scholar
• Stegner D, Nieswandt B. Platelet receptor signaling in thrombus formation. J Mol Med (Berl). 2011;89:109–121.
   PubMed Web of Science ®Google Scholar
• Tedder TF. Cell-surface receptor shedding: A means of regulating function. Am J Respir Cell Mol Biol 1991;5:305–306.
   PubMed Web of Science ®Google Scholar
• Hayashida K, Bartlett AH, Chen Y, Park PW. Molecular and cellular mechanisms of ectodomain shedding. Anat Rec (Hoboken) 2010;293:925–937.
   PubMedGoogle Scholar
• Fong KP, Barry C, Tran AN, Traxler EA, Wannemacher KM, Tang HY, Speicher KD, Blair IA, Speicher DW, Grosser T, et al. Deciphering the human platelet sheddome. Blood 2011;117:e15–26.
   PubMed Web of Science ®Google Scholar
• Scheller J, Chalaris A, Garbers C, Rose-John S. ADAM17: A molecular switch to control inflammation and tissue regeneration. Trends Immunol 2011;32:380–387.
   PubMed Web of Science ®Google Scholar
• Al-Tamimi M, Arthur JF, Gardiner E, Andrews RK. Focusing on plasma glycoprotein VI. Thromb Haemost 2012;107:648–655.
   PubMed Web of Science ®Google Scholar
• Burkhart JM, Vaudel M, Gambaryan S, Radau S, Walter U, Martens L, Geiger J, Sickmann A, Zahedi RP. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 2012;120:82.
   Web of Science ®Google Scholar
• Ramakrishnan V, Reeves PS, DeGuzman F, Deshpande U, Ministri-Madrid K, DuBridge RB, Phillips DR. Increased thrombin responsiveness in platelets from mice lacking glycoprotein V. Proc Natl Acad Sci USA 1999;96:13336–13341.
   PubMed Web of Science ®Google Scholar
• Kahn ML, Diacovo TG, Bainton DF, Lanza F, Trejo J, Coughlin SR. Glycoprotein V-deficient platelets have undiminished thrombin responsiveness and do not exhibit a Bernard-Soulier phenotype. Blood 1999;94:4112–121.
   PubMed Web of Science ®Google Scholar
• Canobbio I, Balduini C, Torti M. Signalling through the platelet glycoprotein Ib-V-IX complex. Cell Signal 2004;16:1329–1344.
   PubMed Web of Science ®Google Scholar
• Nesbitt WS, Westein E, Tovar-Lopez FJ, Tolouei E, Mitchell A, Fu J, Carberry J, Fouras A, Jackson SP. A shear gradient-dependent platelet aggregation mechanism drives thrombus formation. Nat Med 2009;15:665–673.
   PubMed Web of Science ®Google Scholar
• Ruggeri ZM, Orje JN, Habermann R, Federici AB, Reininger AJ. Activation-independent platelet adhesion and aggregation under elevated shear stress. Blood 2006;108:1903–1910.
   PubMed Web of Science ®Google Scholar
• Savage B, Saldívar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996;84:289–297.
   PubMed Web of Science ®Google Scholar
• Andrews RK, Gardiner EE, Shen Y, Whisstock JC, Berndt MC. Glycoprotein Ib-IX-V. Int J Biochem Cell Biol 2003;35:1170–1174.
   PubMed Web of Science ®Google Scholar
• Chandraratne S, von Bruehl ML, Pagel JI, Stark K, Kleinert E, Konrad I, Farschtschi S, Coletti R, Gärtner F, Chillo O, et al. Critical role of platelet glycoprotein ibα in arterial remodeling. Arterioscler Thromb Vasc Biol 2015;35:589–597.
   PubMed Web of Science ®Google Scholar
• Kaplan ZS, Zarpellon A, Alwis I, Yuan Y, McFadyen J, Ghasemzadeh M, Schoenwaelder SM, Ruggeri ZM, Jackson SP. Thrombin-dependent intravascular leukocyte trafficking regulated by fibrin and the platelet receptors GPIb and PAR4. Nat Commun 2015;6:7835.
   PubMed Web of Science ®Google Scholar
• Petri B, Broermann A, Li H, Khandoga AG, Zarbock A, Krombach F, Goerge T, Schneider SW, Jones C, Nieswandt B, et al. von Willebrand factor promotes leukocyte extravasation. Blood 2010;116:4712–4719.
   PubMed Web of Science ®Google Scholar
• Verschoor A, Neuenhahn M, Navarini AA, Graef P, Plaumann A, Seidlmeier A, Nieswandt B, Massberg S, Zinkernagel RM, Hengartner H, et al. A platelet-mediated system for shuttling blood-borne bacteria to CD8α+ dendritic cells depends on glycoprotein GPIb and complement C3. Nat Immunol 2011;12:1194–1201.
   PubMed Web of Science ®Google Scholar
• Langer HF, Choi EY, Zhou H, Schleicher R, Chung KJ, Tang Z, Göbel K, Bdeir K, Chatzigeorgiou A, Wong C, et al. Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res 2012;110:1202–1210.
   PubMed Web of Science ®Google Scholar
• Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation 2007;115:2323–2330.
   PubMed Web of Science ®Google Scholar
• Beer JH, Büchi L, Steiner B. Glycocalicin: A new assay–the normal plasma levels and its potential usefulness in selected diseases. Blood 1994;83:691–702.
   PubMed Web of Science ®Google Scholar
• Reiss K, Saftig P. The “a disintegrin and metalloprotease” (ADAM) family of sheddases: physiological and cellular functions. Semin Cell Dev Biol 2009;20:126–137.
   PubMed Web of Science ®Google Scholar
• Andrews RK, Karunakaran D, Gardiner EE, Berndt MC. Platelet receptor proteolysis: a mechanism for downregulating platelet reactivity. Arterioscler Thromb Vasc Biol 2007;27:1511–1520.
   PubMed Web of Science ®Google Scholar
• Andrews RK, Munday AD, Mitchell CA, Berndt MC. Interaction of calmodulin with the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex Blood 2001;98:681–687.
   Google Scholar
• Gardiner EE, Karunakaran D, Shen Y, Arthur JF, Andrews RK, Berndt MC. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases. J Thromb Haemost 2007;5:1530–1537.
   PubMed Web of Science ®Google Scholar
• Aktas B, Pozgajova M, Bergmeier W, Sunnarborg S, Offermanns S, Lee D, Wagner DD, Nieswandt B. Aspirin induces platelet receptor shedding via ADAM17 (TACE). J Biol Chem 2005;280:39716–39722.
   PubMed Web of Science ®Google Scholar
• Liang X, Russell SR, Estelle S, Jones LH, Cho S, Kahn ML, Berndt MC, Bunting ST, Ware J, Li R. Specific inhibition of ectodomain shedding of glycoprotein Ibα by targeting its juxtamembrane shedding cleavage site. J Thromb Haemost 2013;11:2155–2162.
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Piffath CL, Cheng G, Dole VS, Zhang Y, von Andrian UH, Wagner DD. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates GPIbalpha shedding from platelets in vitro and in vivo. Circ Res 2004;95:677–683.
   PubMed Web of Science ®Google Scholar
• Bender M, Hofmann S, Stegner D, Chalaris A, Bösl M, Braun A, Scheller J, Rose-John S, Nieswandt B. Differentially regulated GPVI ectodomain shedding by multiple platelet-expressed proteinases. Blood 2010;116:3347–3355.
   PubMed Web of Science ®Google Scholar
• Gardiner EE, Andrews RK. Platelet receptor expression and shedding: glycoprotein Ib-IX-V and glycoprotein VI. Transfus Med Rev 2014;28:56–60.
   PubMed Web of Science ®Google Scholar
• Dong JF, Gao S, López JA. Synthesis, assembly, and intracellular transport of the platelet glycoprotein Ib-IX-V complex. J Biol Chem 1998;273:31449–31454.
   PubMed Web of Science ®Google Scholar
• Moog S, Mangin P, Lenain N, Strassel C, Ravanat C, Schuhler S, Freund M, Santer M, Kahn M, Nieswandt B, et al. Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood 2001;98:1038–1046.
   PubMed Web of Science ®Google Scholar
• Azorsa DO, Moog S, Ravanat C, Schuhler S, Folléa G, Cazenave JP, Lanza F. Measurement of GPV released by activated platelets using a sensitive immunocapture ELISA–its use to follow platelet storage in transfusion. Thromb Haemost 1999;81:131–138.
   PubMed Web of Science ®Google Scholar
• Ravanat C, Morales M, Azorsa DO, Moog S, Schuhler S, Grunert P, Loew D, Van Dorsselaer A, Cazenave JP, Lanza F. Gene cloning of rat and mouse platelet glycoprotein V: Identification of megakaryocyte-specific promoters and demonstration of functional thrombin cleavage. Blood 1997;89:3253–3262.
   PubMed Web of Science ®Google Scholar
• Kahn M, Zheng Y, Huang W, Bigornia V, Zeng D, Moff S, Farese R, Tam C, Coughlin S. A dual thrombin receptor system for platelet activation. Nature 1998;394:690–694.
   PubMed Web of Science ®Google Scholar
• Ni H, Ramakrishnan V, Ruggeri ZM, Papalia JM, Phillips DR, Wagner DD. Increased thrombogenesis and embolus formation in mice lacking glycoprotein V. Blood 2001;98:368–373.
   PubMed Web of Science ®Google Scholar
• Nonne C, Hechler B, Cazenave JPP, Gachet C, Lanza F. Reassessment of in vivo thrombus formation in glycoprotein V deficient mice backcrossed on a C57Bl/6 strain. J Thromb Haemost 2008;6:210–212.
   PubMed Web of Science ®Google Scholar
• Rabie T, Strehl A, Ludwig A, Nieswandt B. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J Biol Chem 2005;280:14462–14468.
   PubMed Web of Science ®Google Scholar
• Wolff V, Aleil B, Giroud M, Lorenzini JL, Meyer N, Wiesel ML, Cazenave JP, Lanza F. Soluble platelet glycoprotein V is a marker of thrombosis in patients with ischemic stroke. Stroke 2005;36:e17–9.
   PubMed Web of Science ®Google Scholar
• Berlanga O, Bori-Sanz T, James JR, Frampton J, Davis SJ, Tomlinson MG, Watson SP. Glycoprotein VI oligomerization in cell lines and platelets. J Thromb Haemost 2007;5:1026–1033.
   PubMed Web of Science ®Google Scholar
• Dütting S, Bender M, Nieswandt B. Platelet GPVI: A target for antithrombotic therapy?! Trends Pharmacol Sci 2012;33:583–590.
   PubMed Web of Science ®Google Scholar
• Moroi M, Jung S. Platelet glycoprotein VI: Its structure and function. Thromb Res 2004;114:221–233.
   PubMed Web of Science ®Google Scholar
• Watson SP, Herbert JM, Pollitt AY. GPVI and CLEC-2 in hemostasis and vascular integrity. J Thromb Haemost 2010;8:1456–1467.
   PubMed Web of Science ®Google Scholar
• Varga-Szabo D, Braun A, Nieswandt B. Calcium signaling in platelets. J Thromb Haemost 2009;7:1057–1066.
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Varga-Szabo D, Elvers M. Integrins in platelet activation. J Thromb Haemost 2009;7(Suppl 1):206–209.
   PubMed Web of Science ®Google Scholar
• Inoue O, Suzuki-Inoue K, McCarty OJ, Moroi M, Ruggeri ZM, Kunicki T, Ozaki Y, Watson SP. Laminin stimulates spreading of platelets through integrin alpha6beta1-dependent activation of GPVI. Blood 2006;107:1405–1412.
   PubMed Web of Science ®Google Scholar
• Schaff M, Tang C, Maurer E, Bourdon C, Receveur N, Eckly A, Hechler B, Arnold C, de Arcangelis A, Nieswandt B, et al. Integrin α6β1 is the main receptor for vascular laminins and plays a role in platelet adhesion, activation, and arterial thrombosis. Circulation 2013;128:541–552.
   PubMed Web of Science ®Google Scholar
• Riba R, Hughes CE, Graham A, Watson SP, Naseem KM. Globular adiponectin induces platelet activation through the collagen receptor GPVI-Fc receptor gamma chain complex. J Thromb Haemost 2008;6:1012–1020.
   PubMed Web of Science ®Google Scholar
• Seizer P, Borst O, Langer HF, Bültmann A, Münch G, Herouy Y, Stellos K, Krämer B, Bigalke B, Büchele B, et al. EMMPRIN (CD147) is a novel receptor for platelet GPVI and mediates platelet rolling via GPVI-EMMPRIN interaction. Thromb Haemost 2009;101:682–686.
   PubMed Web of Science ®Google Scholar
• Alshehri OM, Hughes CE, Montague S, Watson SK, Frampton J, Bender M, Watson SP. Fibrin activates GPVI in human and mouse platelets. Blood 2015;126:1601–1608.
   PubMed Web of Science ®Google Scholar
• Mammadova-Bach E, Ollivier V, Loyau S, Schaff M, Dumont B, Favier R, Freyburger G, Latger-Cannard V, Nieswandt B, Gachet C, et al. Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation. Blood 2015;126:683–691.
   PubMed Web of Science ®Google Scholar
• Dumont B, Lasne D, Rothschild C, Bouabdelli M, Ollivier V, Oudin C, Ajzenberg N, Grandchamp B, Jandrot-Perrus M. Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations. Blood 2009;114:1900–1903.
   PubMed Web of Science ®Google Scholar
• Hermans C, Wittevrongel C, Thys C, Smethurst PA, Van Geet C, Freson K. A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder. J Thromb Haemost 2009;7:1356–1363.
   PubMed Web of Science ®Google Scholar
• Arthur JF, Dunkley S, Andrews RK. Platelet glycoprotein VI-related clinical defects. Br J Haematol 2007;139:363–372.
   PubMed Web of Science ®Google Scholar
• Gardiner EE, Arthur JF, Kahn ML, Berndt MC, Andrews RK. Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase. Blood 2004;104:3611–3617.
   PubMed Web of Science ®Google Scholar
• Stephens G, Yan Y, Jandrot-Perrus M, Villeval JL, Clemetson KJ, Phillips DR. Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen. Blood 2005;105:186–191.
   PubMed Web of Science ®Google Scholar
• Al-Tamimi M, Tan CW, Qiao J, Pennings GJ, Javadzadegan A, Yong AS, Arthur JF, Davis AK, Jing J, Mu FT, et al. Pathologic shear triggers shedding of vascular receptors: a novel mechanism for down-regulation of platelet glycoprotein VI in stenosed coronary vessels. Blood 2012;119:4311–4320.
   PubMed Web of Science ®Google Scholar
• Al-Tamimi M, Grigoriadis G, Tran H, Paul E, Servadei P, Berndt MC, Gardiner EE, Andrews RK. Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa. Blood 2011;117:3912–3920.
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Rabie T, Strehl A, Piffath CL, Prostredna M, Wagner DD, Nieswandt B. GPVI down-regulation in murine platelets through metalloproteinase-dependent shedding. Thrombosis and haemostasis 2004;91:951–958.
   PubMed Web of Science ®Google Scholar
• Duerschmied D, Canault M, Lievens D, Brill A, Cifuni SM, Bader M, Wagner DD. Serotonin stimulates platelet receptor shedding by tumor necrosis factor-alpha-converting enzyme (ADAM17). J Thromb Haemost 2009;7:1163–1171.
   PubMed Web of Science ®Google Scholar
• Nieswandt B, Schulte V, Bergmeier W, Mokhtari-Nejad R, Rackebrandt K, Cazenave JP, Ohlmann P, Gachet C, Zirngibl H. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med 2001;193:459–469.
   PubMed Web of Science ®Google Scholar
• Boylan B, Berndt MC, Kahn ML, Newman PJ. Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: Development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents. Blood 2006;108:908–914.
   PubMed Web of Science ®Google Scholar
• Rabie T, Varga-Szabo D, Bender M, Pozgaj R, Lanza F, Saito T, Watson SP, Nieswandt B. Diverging signaling events control the pathway of GPVI down-regulation in vivo. Blood 2007;110:529–535.
   PubMed Web of Science ®Google Scholar
• Takayama H, Hosaka Y, Nakayama K, Shirakawa K, Naitoh K, Matsusue T, Shinozaki M, Honda M, Yatagai Y, Kawahara T, et al. A novel antiplatelet antibody therapy that induces cAMP-dependent endocytosis of the GPVI/Fc receptor gamma-chain complex. J Clin Invest 2008;118:1785–1795.
   PubMed Web of Science ®Google Scholar
• Al-Tamimi M, Mu FT, Moroi M, Gardiner EE, Berndt MC, Andrews RK. Measuring soluble platelet glycoprotein VI in human plasma by ELISA. Platelets 2009;20:143–149.
   PubMed Web of Science ®Google Scholar
• Bender M, May F, Lorenz V, Thielmann I, Hagedorn I, Finney BA, Vögtle T, Remer K, Braun A, Bösl M, et al. Combined in vivo depletion of glycoprotein VI and C-type lectin-like receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice. Arterioscler Thromb Vasc Biol 2013;33:926–934.
   PubMed Web of Science ®Google Scholar
• Grüner S, Prostredna M, Aktas B, Moers A, Schulte V, Krieg T, Offermanns S, Eckes B, Nieswandt B. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy. Circulation 2004;110:2946–2951.
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K, Fuller GL, García A, Eble J, Pöhlmann S, Inoue O, Gartner TK, Hughan SC, Pearce AC, Laing GD, et al. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2. Blood 2006;107:542–549.
   PubMed Web of Science ®Google Scholar
• Gitz E, Pollitt AY, Gitz-Francois JJ, Alshehri O, Mori J, Montague S, Nash GB, Douglas MR, Gardiner EE, Andrews RK, et al. CLEC-2 expression is maintained on activated platelets and on platelet microparticles. Blood 2014;124:2262–2270.
   PubMed Web of Science ®Google Scholar
• Watson SP, Lowe K, Finney BA. Platelets in lymph vessel development and integrity. Adv Anat Embryol Cell Biol 2014;214:93–105.
   PubMed Web of Science ®Google Scholar
• Hess PR, Rawnsley DR, Jakus Z, Yang Y, Sweet DT, Fu J, Herzog B, Lu M, Nieswandt B, Oliver G, et al. Platelets mediate lymphovenous hemostasis to maintain blood-lymphatic separation throughout life. J Clin Invest 2014;124:273–284.
   PubMed Web of Science ®Google Scholar
• Bénézech C, Nayar S, Finney BA, Withers DR, Lowe K, Desanti GE, Marriott CL, Watson SP, Caamaño JH, Buckley CD, et al. CLEC-2 is required for development and maintenance of lymph nodes. Blood 2014;123:3200–3207.
   PubMed Web of Science ®Google Scholar
• May F, Hagedorn I, Pleines I, Bender M, Vögtle T, Eble J, Elvers M, Nieswandt B. CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis. Blood 2009;114:3464–3472.
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K, Inoue O, Ding G, Nishimura S, Hokamura K, Eto K, Kashiwagi H, Tomiyama Y, Yatomi Y, Umemura K, et al. Essential in vivo roles of the C-type lectin receptor CLEC-2: Embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. J Biol Chem 2010;285:24494–24507.
   PubMed Web of Science ®Google Scholar
• Lorenz V, Stegner D, Stritt S, Vögtle T, Kiefer F, Witke W, Schymeinsky J, Watson SP, Walzog B, Nieswandt B. Targeted downregulation of platelet CLEC-2 occurs through Syk-independent internalization. Blood 2015;125:4069–4077.
   PubMed Web of Science ®Google Scholar
• Gardiner EE, Karunakaran D, Arthur JF, Mu FT, Powell MS, Baker RI, Hogarth PM, Kahn ML, Andrews RK, Berndt MC. Dual ITAM-mediated proteolytic pathways for irreversible inactivation of platelet receptors: de-ITAM-izing FcgammaRIIa. Blood 2008;111:165–174.
   PubMed Web of Science ®Google Scholar
• Zaiss M, Hirtreiter C, Rehli M, Rehm A, Kunz-Schughart LA, Andreesen R, Hennemann B. CD84 expression on human hematopoietic progenitor cells. Exp Hematol 2003;31:798–805.
   PubMed Web of Science ®Google Scholar
• Nanda N, Andre P, Bao M, Clauser K, Deguzman F, Howie D, Conley PB, Terhorst C, Phillips DR. Platelet aggregation induces platelet aggregate stability via SLAM family receptor signaling. Blood 2005;106:3028–3034.
   PubMed Web of Science ®Google Scholar
• Hofmann S, Braun A, Pozgaj R, Morowski M, Vögtle T, Nieswandt B. Mice lacking the SLAM family member CD84 display unaltered platelet function in hemostasis and thrombosis. PloS One 2014;9.
   Google Scholar
• Hofmann S, Vögtle T, Bender M, Rose-John S, Nieswandt B. The SLAM family member CD84 is regulated by ADAM10 and calpain in platelets. J Thromb Haemost 2012;10:2581–2592.
   PubMed Web of Science ®Google Scholar
• Siebold C, Jones EY. Structural insights into semaphorins and their receptors. Semin Cell Dev Biol 2013;24:139–145.
   PubMed Web of Science ®Google Scholar
• Zhu L, Bergmeier W, Wu J, Jiang H, Stalker TJ, Cieslak M, Fan R, Boumsell L, Kumanogoh A, Kikutani H, et al. Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury. Proc Natl Acad Sci USA 2007;104:1621–1626.
   PubMed Web of Science ®Google Scholar
• Wannemacher KM, Zhu L, Jiang H, Fong KP, Stalker TJ, Lee D, Tran AN, Neeves KB, Maloney S, Kumanogoh A, et al. Diminished contact-dependent reinforcement of Syk activation underlies impaired thrombus growth in mice lacking Semaphorin 4D. Blood 2010;116:5707–5715.
   PubMed Web of Science ®Google Scholar
• Lievens D, Eijgelaar WJ, Biessen EA, Daemen MJ, Lutgens E. The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thromb Haemost 2009;102:206–214.
   PubMed Web of Science ®Google Scholar
• Furman MI, Krueger LA, Linden MD, Barnard MR, Frelinger AL, Michelson AD. Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization. J Am Coll Cardiol 2004;43:2319–2325.
   PubMed Web of Science ®Google Scholar
• Rahman M, Zhang S, Chew M, Syk I, Jeppsson B, Thorlacius H. Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis. J Thromb Haemost 2013;11:1385–1398.
   PubMed Web of Science ®Google Scholar
• Weber C, Fraemohs L, Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 2007;7:467–477.
   PubMed Web of Science ®Google Scholar
• Naik MU, Stalker TJ, Brass LF, Naik UP. JAM-A protects from thrombosis by suppressing integrin αIIbβ3-dependent outside-in signaling in platelets. Blood 2012;119:3352–3360.
   PubMed Web of Science ®Google Scholar
• Karshovska E, Zhao Z, Blanchet X, Schmitt MM, Bidzhekov K, Soehnlein O, von Hundelshausen P, Mattheij NJ, Cosemans JMEM, Megens RT, et al. Hyperreactivity of junctional adhesion molecule A-deficient platelets accelerates atherosclerosis in hyperlipidemic mice. Circ Res 2015;116:587–599.
   PubMed Web of Science ®Google Scholar
• Koenen RR, Pruessmeyer J, Soehnlein O, Fraemohs L, Zernecke A, Schwarz N, Reiss K, Sarabi A, Lindbom L, Hackeng TM, et al. Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. Blood 2009;113:4799–4809.
   PubMed Web of Science ®Google Scholar
• André P. P-selectin in haemostasis. Br J Haematol 2004;126:298–306.
   PubMed Web of Science ®Google Scholar
• Ludwig RJ, Schultz JE, Boehncke WH, Podda M, Tandi C, Krombach F, Baatz H, Kaufmann R, von Andrian UH, Zollner TM. Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules. J Invest Dermatol 2004;122:830–836.
   PubMed Web of Science ®Google Scholar
• Berger G, Hartwell DW, Wagner DD. P-Selectin and platelet clearance. Blood 1998;92:4446–4452.
   PubMed Web of Science ®Google Scholar
• Dole VS, Bergmeier W, Patten IS, Hirahashi J, Mayadas TN, Wagner DD. PSGL-1 regulates platelet P-selectin-mediated endothelial activation and shedding of P-selectin from activated platelets. Thromb Haemost 2007;98:806–812.
   PubMed Web of Science ®Google Scholar
• Du X, Saido TC, Tsubuki S, Indig FE, Williams MJ, Ginsberg MH. Calpain cleavage of the cytoplasmic domain of the integrin beta 3 subunit. J Biol Chem 1995;270:26146–26151.
   PubMed Web of Science ®Google Scholar
• Xi X, Bodnar RJ, Li Z, Lam SC, Du X. Critical roles for the COOH-terminal NITY and RGT sequences of the integrin beta3 cytoplasmic domain in inside-out and outside-in signaling. J Cell Biol 2003;162:329–339.
   PubMed Web of Science ®Google Scholar
• Chen Z, Mondal NK, Ding J, Koenig SC, Slaughter MS, Griffith BP, Wu ZJ. Activation and shedding of platelet glycoprotein IIb/IIIa under non-physiological shear stress. Mol Cell Biochem 2015;409:93–101.
   PubMed Web of Science ®Google Scholar
• Newman PJ. The biology of PECAM-1. J Clin Invest 1997;100:9.
   Web of Science ®Google Scholar
• Falati S, Patil S, Gross PL, Stapleton M, Merrill-Skoloff G, Barrett NE, Pixton KL, Weiler H, Cooley B, Newman DK, et al. Platelet PECAM-1 inhibits thrombus formation in vivo. Blood 2006;107:535–541.
   PubMed Web of Science ®Google Scholar
• Dhanjal TS, Ross EA, Auger JM, McCarty OJ, Hughes CE, Senis YA, Buckley CD, Watson SP. Minimal regulation of platelet activity by PECAM-1. Platelets 2007;18:56–67.
   PubMed Web of Science ®Google Scholar
• Naganuma Y, Satoh K, Yi Q, Asazuma N, Yatomi Y, Ozaki Y. Cleavage of platelet endothelial cell adhesion molecule-1 (PECAM-1) in platelets exposed to high shear stress. J Thromb Haemost 2004;2:1998–2008.
   PubMed Web of Science ®Google Scholar
• Wong MX, Harbour SN, Wee JL, Lau LM, Andrews RK, Jackson DE. Proteolytic cleavage of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) is regulated by a calmodulin-binding motif. FEBS Lett 2004;568:70–78.
   PubMed Web of Science ®Google Scholar
• Zaremba J, Losy J. sPECAM-1 in serum and CSF of acute ischaemic stroke patients. Acta Neurol Scand 2002;106:292–298.
   PubMed Web of Science ®Google Scholar
• Soeki T, Tamura Y, Shinohara H, Sakabe K, Onose Y, Fukuda N. Increased soluble platelet/endothelial cell adhesion molecule-1 in the early stages of acute coronary syndromes. Int J Cardiol 2003;90:261–268.
   PubMed Web of Science ®Google Scholar
• Ilan N, Mohsenin A, Cheung L, Madri JA. PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics. FASEB J 2001;15:362–372.
   PubMed Web of Science ®Google Scholar
• Wang SZ, Smith PK, Lovejoy M, Bowden JJ, Alpers JH, Forsyth KD. Shedding of L-selectin and PECAM-1 and upregulation of Mac-1 and ICAM-1 on neutrophils in RSV bronchiolitis. Am J Physiol 1998;275:L983–9.
   PubMed Web of Science ®Google Scholar